Product Detail
Trazodone Hydrochloride
Trazodone Hydrochloride API
Stock Status: In Stock
Login to view price
Live
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Category
API
API Family
Trazodone Hydrochloride
Storage
Store at refrigerator (2-8°C) for long term storage
Hazard Information
Refer MSDS for accurate information.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
CAT No. CS-O-05402
CAS No. 25332-39-2
Research Use
Trazodone Hydrochloride Product Information
Trazodone Hydrochloride is listed under API. It is associated with Trazodone Hydrochloride and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-O-05402.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Trazodone Hydrochloride
CAS No.
25332-39-2
CAT No.
CS-O-05402
Molecular Formula
C₁₉H₂₃Cl₂N₅O
Molecular Weight
408.32
Category
API Family
Storage Condition
Store at refrigerator (2-8°C) for long term storage
SMILES
O=C1N(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)N=C4C=CC=CN41.[H]Cl
IUPAC Name
2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;hydrochloride
Purity by HPLC
Not less than 95%
Hazard Compound
Refer MSDS for accurate information.
Description
Overview
Trazodone hydrochloride is a serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depres
Synonyms
2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;hydrochloride
Application Notes
Trazodone hydrochloride is a serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depres
References
"Silvestrini; B,; et al,: Eur, J, Pharmcol,; 12; 231 (1970); Brogden; R,N,; et al,: Drugs; 21; 401 (1981); Gorcki; D,; et al,: Anal, Profiles Drug Subs,; 16; 693 (1986);"
